Northern Indiana Cancer Research Consortium IRB

Form 483

South Bend, Indiana, United StatesFEI 3009194999Issued February 21, 2012

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3009194999.

Observations2

Issue DateFebruary 21, 2012

StatusNo Warning Letter

Related Inspections2

Establishment Details

Firm: Northern Indiana Cancer Research Consortium IRB
Location: South Bend, Indiana, United States
FEI Number: 3009194999
Product Type: Drugs
Issue Date: February 21, 2012
Country: United States

Inspection History, 2012 to 2013

NAI1

OAI1

NAI means No Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Northern Indiana Cancer Research Consortium IRB FDA Form 483, South Bend, Indiana, February 21, 2012